Treatment of Plantar Warts

Sohag University

Status and phase: Unknown; Phase 3

Conditions: Plantar Wart

Treatments: Drug: Topical 45% hydrogen peroxide solution; Drug: Topical 30%Potassium hydroxide solution

Study type: Interventional

Funder types: Other

Identifiers

NCT05198180

Sohag-Mes-21-11-07

Details and patient eligibility

About

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Enrollment: 60 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed diagnosis by clinical and dermoscopic examination of plantar warts

Exclusion criteria

• history of hypersensitivity to any component used in this study
• pregnancy and breastfeeding
• patients who receive immune suppressive therapy
• patients who received any wart treatments during the last 2 months before enrollent in the study
• patients who refused participation in the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Potassium hydroxide group

Active Comparator group

Description:

Patients with plantar warts will apply topical 30% potassium hydroxide solutions on warts

Treatment:

Drug: Topical 30%Potassium hydroxide solution

Hydrogen peroxide group

Active Comparator group

Description:

Patients with plantar warts will use topical 45% hydrogen peroxide solution on warts

Treatment:

Drug: Topical 45% hydrogen peroxide solution